glp-1 news today october 20 2025 Mapping the effectiveness and risks of receptor agonists Weight maintenance after discontinuation of

It has antimicrobial properties and can help reduce the appearance of redness and blemishes while strengthening the skins natural defences

Oral Wegovy got approved in December 2025, and oral orforglipron (Foundayo) in April 2026

doi: 10.1016/j.intimp.2014.07.010 157 RichterGFeddersenOWagnerUBarthPGkeRGkeB

Dosing patterns for hormonal phases While the standard prescribing information for GLP-1 medications like semaglutide or tirzepatide does not include official information for customized dosing based on a patients hormonal phases, there is emerging clinical practice and research focusing on personalized dosing strategies, particularly for women experiencing hormonal shifts